BRAF a serine/threonine kinase, known to activate the MAPK pathway has been found mutated in several tumours, namely melanoma, colorectal carcinoma and thyroid carcinoma [3,4,26]. This evidence concerns the gene MARK2 and thyroid gland carcinoma.